Phase II study of oxaliplatin in poor-prognosis non-small cell lung cancer (NSCLC)

This publication has 11 references indexed in Scilit:

• Single agent activity of oxaliplatin in heavily pretreated advanced epithelial ovarian cancer
  Annals of Oncology, 1996
• Phase II trial of oxaliplatin (L-OHP) in advanced, recurrent and/or metastatic squamous cell carcinoma of the head and neck
  Oral Oncology, 1996
• Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines
  Annals of Oncology, 1996
• Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials
  BMJ, 1995
• New Chemotherapeutic Agents for Non-small Cell Lung Cancer
  Chest, 1995
• Chronomodulated Versus Fixed-Infusion—Rate Delivery of Ambulatory Chemotherapy With Oxaliplatin, Fluorouracil, and Folinic Acid (Leucovorin) in Patients With Colorectal Cancer Metastases: a Randomized Multi-institutional Trial
  JNCI Journal of the National Cancer Institute, 1994
• Oxaliplatin activity against metastatic colorectal cancer. A phase II study of 5-day continuous venous infusion at circadian rhythm modulated rate
  European Journal Of Cancer, 1993
• Oxaliplatin (L-OHP®): A new platinum analog: Active in refractory/relapsed intermediate and low crade non-Hodgkin lymphoma (NHL): A phase I–II study
  European Journal Of Cancer, 1993
• Phase I study of oxaliplatin in patients with advanced cancer
  Cancer Chemotherapy and Pharmacology, 1990
• Oxalato-platinum or 1-OHP, a third-generation platinum complex: an experimental and clinical appraisal and preliminary comparison with cis-platinum and carboplatinum
  Biomedicine & Pharmacotherapy, 1989